Latest Regulatory Development News

Northern Minerals propels its Browns Range Heavy Rare Earths Project forward with a planned Final Investment Decision in Q3 2026 and a significant 40% increase in the Dazzler Deposit resource.

Sprintex boosted its commercial footprint in the June quarter with a 65% order book increase from Mest Water, a paid trial at Taiwan's TSMC, and Dutch regulatory clearance lifting key uncertainties.

Frasers Group has extended the deadline for its on-market takeover bid for Accent Group shares to 30 September 2026, maintaining all other offer terms unchanged.

ECS Botanics delivered a fourth consecutive quarter of positive operating cash flow in Q4 FY26, with a full-year turnaround of $5.9 million. The company’s branded B2C revenue surged 31% year-on-year, supported by product launches and European market expansion.

The Federal Treasurer has barred three foreign shareholders from exercising voting rights in Northern Minerals due to non-compliance with mandated share divestments, intensifying regulatory oversight amid ongoing FIRB investigations.

Rural Funds Group has exchanged contracts to sell five agricultural assets for $255.6 million, trimming gearing to a pro forma 31.6% and reaffirming its FY26 income forecast.

Qoria Limited marked a turning point in FY25, delivering 25% growth in Annual Recurring Revenue and a 684% jump in underlying EBITDA, setting sights on 20% EBITDA margin in FY26 amid global digital safety expansion.

Island Pharmaceuticals is progressing its broad-spectrum antiviral Galidesivir amid a severe Ebola outbreak, securing government approvals in Uganda and outlining a dual clinical and regulatory development pathway targeting multiple deadly filoviruses.

PEXA faces a proposed 20% cut in regulated ELNO service fees, risking a $70 million revenue reduction over a year. The company urges a phased approach to mitigate business impact as IPART opens public consultation.

Resolution Minerals has completed a third of its 2026 drill program at Golden Gate South, Idaho, with 16 diamond core holes totaling 4,470 metres. The drilling aims to delineate extensions of gold and tungsten mineralisation near historical workings, supporting resource growth at the Horse Heaven project.

Booster Innovation Fund reported a $1.593 million profit for the year ended March 2026, supported by increased net assets. However, valuation risks persist due to early-stage investments and recent capital raises at lower prices.

Emyria has trained its first cohort of 31 clinicians in New South Wales, paving the way for its inaugural Sydney Empax clinic at Matilda Nepean, scheduled to open in Q3 2026.